Correlation Between Salesforce and Xvivo Perfusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Xvivo Perfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Xvivo Perfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Xvivo Perfusion AB, you can compare the effects of market volatilities on Salesforce and Xvivo Perfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Xvivo Perfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Xvivo Perfusion.

Diversification Opportunities for Salesforce and Xvivo Perfusion

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Salesforce and Xvivo is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Xvivo Perfusion AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xvivo Perfusion AB and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Xvivo Perfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xvivo Perfusion AB has no effect on the direction of Salesforce i.e., Salesforce and Xvivo Perfusion go up and down completely randomly.

Pair Corralation between Salesforce and Xvivo Perfusion

Considering the 90-day investment horizon Salesforce is expected to generate 1.55 times less return on investment than Xvivo Perfusion. But when comparing it to its historical volatility, Salesforce is 1.61 times less risky than Xvivo Perfusion. It trades about 0.09 of its potential returns per unit of risk. Xvivo Perfusion AB is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  2,280  in Xvivo Perfusion AB on August 24, 2024 and sell it today you would earn a total of  1,843  from holding Xvivo Perfusion AB or generate 80.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

Salesforce  vs.  Xvivo Perfusion AB

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Xvivo Perfusion AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Salesforce and Xvivo Perfusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Xvivo Perfusion

The main advantage of trading using opposite Salesforce and Xvivo Perfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Xvivo Perfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will offset losses from the drop in Xvivo Perfusion's long position.
The idea behind Salesforce and Xvivo Perfusion AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities